BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 23332923)

  • 1. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.
    Luo MH; Huang YH; Ni YB; Tsang JY; Chan SK; Shao MM; Tse GM
    Hum Pathol; 2013 Jul; 44(7):1241-50. PubMed ID: 23332923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPS1 is a promising marker for all subtypes of breast cancer.
    Lui JW; Tsang JY; Li J; Ko CW; Tam F; Loong TC; Tse GM
    Histopathology; 2024 Apr; 84(5):822-836. PubMed ID: 38173281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups.
    Ni YB; Tsang JY; Chan SK; Tse GM
    Histopathology; 2015 Jul; 67(1):96-105. PubMed ID: 25425335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.
    Sauer N; Matkowski I; Bodalska G; Murawski M; Dzięgiel P; Calik J
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoexpression of the GCDFP-15 Marker in Different Grades of Breast Carcinoma.
    Shirian F; Kheradmand P; Ranjbari N; Shahbazian H; Latifi SM
    Iran J Pathol; 2023; 18(1):75-81. PubMed ID: 37383152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer.
    Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
    Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
    Urbaniak A; Jablonska K; Suchanski J; Partynska A; Szymczak-Kulus K; Matkowski R; Maciejczyk A; Ugorski M; Dziegiel P
    Sci Rep; 2023 Apr; 13(1):6574. PubMed ID: 37085653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Small intestinal metastatic breast cancer: A case report and literature review.
    Li Y; Zhang L; Yu H; Xin X; He J; Yao Y; Liu B; Li R; Xie L
    Front Oncol; 2022; 12():900832. PubMed ID: 36505863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in breast pathology.
    Quinn C; Maguire A; Rakha E
    Histopathology; 2023 Jan; 82(1):140-161. PubMed ID: 36482276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma.
    Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
    Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
    Cimino-Mathews A
    Mod Pathol; 2021 Jan; 34(Suppl 1):62-77. PubMed ID: 33110239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tender pigmented papule in an African-American woman.
    Williams MN; Shipp D; Chung CG
    JAAD Case Rep; 2020 Apr; 6(4):260-262. PubMed ID: 32258292
    [No Abstract]   [Full Text] [Related]  

  • 14. Synchronous Ovarian and Breast Cancers with a Novel Variant in BRCA2 Gene: A Case Report.
    Llinás-Quintero N; Cabrera-Florez E; Mendoza-Fandiño G; Matute-Turizo G; Vasquez-Trespalacios EM; Gallón-Villegas LJ
    Case Rep Oncol Med; 2019; 2019():6958952. PubMed ID: 30723561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalp metastasis from occult primary breast carcinoma: A case report and review of the literature.
    Alizadeh N; Mirpour H; Azimi SZ
    Int J Womens Dermatol; 2018 Dec; 4(4):230-235. PubMed ID: 30627623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
    Urbaniak A; Jablonska K; Podhorska-Okolow M; Ugorski M; Dziegiel P
    Am J Cancer Res; 2018; 8(11):2150-2164. PubMed ID: 30555735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis.
    Hu Y; Liu P; Wu D; Jiang Y
    Onco Targets Ther; 2018; 11():3245-3255. PubMed ID: 29881297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic colonic and gastric polyps from breast cancer resembling hyperplastic polyps.
    Horimoto Y; Hirashima T; Arakawa A; Miura H; Saito M
    Surg Case Rep; 2018 Mar; 4(1):23. PubMed ID: 29572575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages.
    Ihedioha O; Blanchard AA; Balhara J; Okwor I; Jia P; Uzonna J; Myal Y
    Immunol Res; 2018 Apr; 66(2):245-254. PubMed ID: 29536339
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.